Results 101 to 110 of about 16,017 (247)
ABSTRACT Accurate prediction of bioprocess scale‐up is critical for accelerating the deployment of novel and sustainable biomanufacturing systems. However, this remains challenging as multi‐scale data is expensive to generate and mechanistic understanding is often incomplete, leading upscaling decisions to rely heavily on empirical expertise. This work
Harvey Al‐Ramadhan +3 more
wiley +1 more source
Mechanistic Digital Model for Real‐Time Monitoring and Optimization of Adenovirus Production
ABSTRACT Adenoviral vectors are a critical vaccine platform, with billions of vaccine doses administered during the COVID‐19 pandemic. In addition, they are promising therapeutics for cancer treatment. To advance their manufacturing, real‐time monitoring of adenovirus production is essential for process optimization, yield improvement, and product ...
Xingge Xu +4 more
wiley +1 more source
ABSTRACT Modified Vaccinia virus Ankara (MVA) is a potent vector for the development of vaccines and novel cancer treatment strategies. Since it is a non‐replicating virus in human recipients, high infective titers are required for therapeutic efficacy.
Linus G. Weber +5 more
wiley +1 more source
The state of the art in Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics Modeling is presented in this new second edition book. It shows how advanced physical and mathematical methods can expand classical models in order to cover heterogeneous ...
Macheras, Panos, Iliadis, Athanassios
core +1 more source
A Hybrid Mechanistic Model Capturing Lactate Run‐Away and Back‐Metabolism in Mammalian Cell Culture
ABSTRACT Mechanistic modeling is important in biopharmaceutical manufacturing by enabling in‐silico experimentation. However, developing a robust mechanistic model for mammalian cell culture remains challenging due to the complexity of the underlying bioprocesses.
Li Qin +4 more
wiley +1 more source
ABSTRACT Adeno‐associated viruses (AAVs) are the leading vectors for in vivo gene therapy, fueling a growing demand for scalable and robust biomanufacturing processes. Yet, the impact of cell lysis conditions on the performance of midstream and downstream unit operations across serotypes remains poorly characterized.
Arianna Minzoni +20 more
wiley +1 more source
Continuous Capture of Recombinant Adeno‐Associated Virus Particles Using Twin‐Column CaptureSMB
Continuous twin‐column CaptureSMB enables direct capture of secreted rAAV5 from minimally processed perfusion harvest, bypassing lysis, clarification, and concentration steps. Compared to batch capture, it achieves higher yield (+14.3%), greater productivity (+11.4%), and drastically reduced buffer use (−79.2%), while maintaining critical quality ...
Julia M. Müller +11 more
wiley +1 more source
ABSTRACT Inclusion body (IB) processes yielding the recombinant product only as IBs are long‐established in the biopharmaceutical industry. Yet, for recombinant proteins that accumulate both IBs and soluble fraction depending on the selected upstream processing (USP) strategy, the influence of process parameters on the partitioning between both forms ...
Mohamed Elshazly +7 more
wiley +1 more source
Venture Capital in Biopharmaceutics of China [PDF]
生物技术与信息技术产业被公认为是21世纪两大高新技术支柱产业。生物制药作为生物技术产业中最为活跃、进展最快的领域,在西方国家深受风险资本的青睐。在美国,生物制药行业已经超过IT行业成为接受风险资本投资最多的行业。 我国的生物制药和风险投资都是在最近十几年间才开始发展起来的新兴行业,各方面都还不成熟。我国的生物制药行业发展现状揭示了其迫切需要风险资本的帮助。 本文用SWOT分析法分析了风险资本投资于生物制药行业的优、劣势:风险投资能够帮助我国的生物制药企业解决融资困难和缺乏企业营运人才的难题 ...
郑鲲鹏
core

